BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21168405)

  • 1. MicroRNAs in chronic lymphocytic leukemia.
    Ward BP; Tsongalis GJ; Kaur P
    Exp Mol Pathol; 2011 Apr; 90(2):173-8. PubMed ID: 21168405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA in chronic lymphocytic leukemia: transitioning from laboratory-based investigation to clinical application.
    Nana-Sinkam SP; Croce CM
    Cancer Genet Cytogenet; 2010 Dec; 203(2):127-33. PubMed ID: 21156224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of microRNAs in chronic lymphocytic leukemia (Review).
    Zhou XX; Wang X
    Mol Med Rep; 2013 Sep; 8(3):719-25. PubMed ID: 23900739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia.
    Calin GA; Pekarsky Y; Croce CM
    Best Pract Res Clin Haematol; 2007 Sep; 20(3):425-37. PubMed ID: 17707831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia.
    Wang LQ; Chim CS
    Epigenomics; 2015; 7(3):461-73. PubMed ID: 25650645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs in chronic lymphocytic leukemia: miRacle or miRage for prognosis and targeted therapies?
    Van Roosbroeck K; Calin GA
    Semin Oncol; 2016 Apr; 43(2):209-14. PubMed ID: 27040698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs in the pathogeny of chronic lymphocytic leukaemia.
    Nicoloso MS; Kipps TJ; Croce CM; Calin GA
    Br J Haematol; 2007 Dec; 139(5):709-16. PubMed ID: 18021085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance.
    Calin GA; Croce CM
    Semin Oncol; 2006 Apr; 33(2):167-73. PubMed ID: 16616063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53-dependent non-coding RNA networks in chronic lymphocytic leukemia.
    Blume CJ; Hotz-Wagenblatt A; Hüllein J; Sellner L; Jethwa A; Stolz T; Slabicki M; Lee K; Sharathchandra A; Benner A; Dietrich S; Oakes CC; Dreger P; te Raa D; Kater AP; Jauch A; Merkel O; Oren M; Hielscher T; Zenz T
    Leukemia; 2015 Oct; 29(10):2015-23. PubMed ID: 25971364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in microRNA-mediated gene regulation in chronic lymphocytic leukemia.
    Srivastava S; Tsongalis GJ; Kaur P
    Clin Biochem; 2013 Jul; 46(10-11):901-8. PubMed ID: 23518313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181.
    Pekarsky Y; Santanam U; Cimmino A; Palamarchuk A; Efanov A; Maximov V; Volinia S; Alder H; Liu CG; Rassenti L; Calin GA; Hagan JP; Kipps T; Croce CM
    Cancer Res; 2006 Dec; 66(24):11590-3. PubMed ID: 17178851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis.
    Marton S; Garcia MR; Robello C; Persson H; Trajtenberg F; Pritsch O; Rovira C; Naya H; Dighiero G; Cayota A
    Leukemia; 2008 Feb; 22(2):330-8. PubMed ID: 17989717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features.
    Bomben R; Dal-Bo M; Benedetti D; Capello D; Forconi F; Marconi D; Bertoni F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Luciano F; Sozzi E; Cattarossi I; Zucchetto A; Rossi FM; Bulian P; Zucca E; Nicoloso MS; Degan M; Marasca R; Efremov DG; Del Poeta G; Gaidano G; Gattei V
    Clin Cancer Res; 2010 Jan; 16(2):620-8. PubMed ID: 20068100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the pathogenesis of chronic lymphocytic leukemia.
    Klein U; Dalla-Favera R
    Semin Cancer Biol; 2010 Dec; 20(6):377-83. PubMed ID: 21029776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic lesions in chronic lymphocytic leukemia: clinical implications.
    Montserrat E; Moreno C
    Curr Opin Oncol; 2009 Nov; 21(6):609-14. PubMed ID: 19713841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All you need is a Mir-acle: the role of nontranslated RNAs in the suppression of B cell chronic lymphocytic leukemia.
    Lichter P
    Cancer Cell; 2010 Jan; 17(1):3-4. PubMed ID: 20129242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocytochemical detection of bcl-2 and p53 proteins in B-chronic lymphocytic leukemia patients.
    Klobusická M; Kusenda J; Babusíková O
    Neoplasma; 2002; 49(6):387-93. PubMed ID: 12584586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common polymorphism G(-248)A in the promoter region of the bax gene results in significantly shorter survival in patients with chronic lymphocytic Leukemia once treatment is initiated.
    Starczynski J; Pepper C; Pratt G; Hooper L; Thomas A; Milligan D; Bentley P; Fegan C
    J Clin Oncol; 2005 Mar; 23(7):1514-21. PubMed ID: 15735127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of signaling pathways and miRNAs in chronic lymphocytic leukemia.
    Li PP; Wang X
    Chin Med J (Engl); 2013 Nov; 126(21):4175-82. PubMed ID: 24229693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia.
    Braga TV; Evangelista FCG; Gomes LC; Araújo SSDS; Carvalho MDG; Sabino AP
    Biomed Pharmacother; 2017 Aug; 92():864-869. PubMed ID: 28599250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.